Lombard Odier & Cie (Canada)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$24K Hold
300
0.07% 73
2016
Q2
$25K Hold
300
0.09% 59
2016
Q1
$28K Buy
+300
New +$27.1K 0.07% 60
2015
Q2
Sell
-400
Closed -$39K 97
2015
Q1
$39K Hold
400
0.06% 84
2014
Q4
$38K Sell
400
-6,180
-94% -$639K 0.05% 89
2014
Q3
$701K Hold
6,580
0.45% 51
2014
Q2
$546K Buy
6,580
+1,880
+40% +$146K 0.36% 61
2014
Q1
$333K Sell
4,700
-2,600
-36% -$204K 0.26% 65
2013
Q4
$549K Buy
+7,300
New +$508K 0.54% 39

Other funds holding GILD

Lombard Odier & Cie (Canada)'s GILD Position: Q3 2016 in Review

Lombard Odier & Cie (Canada) held its Gilead Sciences (GILD) position steady in Q3 2016 at 300 shares worth $24K. The position accounts for 0.07% of the portfolio, ranked #73.

Lombard Odier & Cie (Canada) first reported a position in GILD in Q4 2013 and has held it in 9 quarters since. The position peaked at $701K in Q3 2014. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Lombard Odier & Cie (Canada) held 300 shares of Gilead Sciences worth $24K as of Q3 2016.
  • Lombard Odier & Cie (Canada) left its Gilead Sciences share count unchanged in Q3 2016.
  • Gilead Sciences made up 0.07% of Lombard Odier & Cie (Canada)'s portfolio in Q3 2016, its #73 holding.
  • Lombard Odier & Cie (Canada) first reported a position in Gilead Sciences in Q4 2013 and has held it in 9 quarters since.
  • Lombard Odier & Cie (Canada)'s Gilead Sciences position peaked at $701K in Q3 2014.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Lombard Odier & Cie (Canada)'s 13F filing for Q3 2016, filed 14 Nov 2016.